Immunome Inc (IMNM)

Mar 24, 2026

Director Philip Wagenheim Sells 65,000 Shares of Immunome Inc (I - GuruFocus

Mar 24, 2026

Mar 23, 2026

Immunome Inc: director Wagenheim sells $1.3m in shares By Investing.com - Investing.com South Africa

Mar 23, 2026

Mar 23, 2026

Immunome (NASDAQ:IMNM) Director Philip Wagenheim Sells 28,200 Shares - MarketBeat

Mar 23, 2026

Mar 23, 2026

Philip Wagenheim Sells 36,800 Shares of Immunome (NASDAQ:IMNM) Stock - MarketBeat

Mar 23, 2026

Mar 23, 2026

Immunome Inc: director Wagenheim sells $1.3m in shares - Investing.com

Mar 23, 2026

Mar 23, 2026

Immunome Director Sold Shares Worth Over $1.3M - TradingView

Mar 23, 2026

Mar 23, 2026

Immunome (IMNM) director sells 65,000 shares in open market - Stock Titan

Mar 23, 2026

Mar 21, 2026

IMNM PE Ratio & Valuation, Is IMNM Overvalued - Intellectia AI

Mar 21, 2026

Mar 21, 2026

Immunome Inc stock surges on breakthrough oncology data, drawing DACH biotech investor interest - AD HOC NEWS

Mar 21, 2026

Mar 21, 2026

Immunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Mar 21, 2026

Mar 20, 2026

Form 144 Immunome Inc. For: 20 March By Investing.com - Investing.com Australia

Mar 20, 2026

Mar 20, 2026

Smart Money: Is Immunome Inc forming a breakout patternQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Mar 20, 2026

Mar 20, 2026

Form 144 Immunome Inc. For: 20 March - Investing.com

Mar 20, 2026

Mar 20, 2026

[144] Immunome Inc. SEC Filing - Stock Titan

Mar 20, 2026

Mar 19, 2026

Behavioral Patterns of IMNM and Institutional Flows - Stock Traders Daily

Mar 19, 2026

Mar 18, 2026

HC Wainwright & Co. initiates coverage of Immunome (IMNM) with buy recommendation - MSN

Mar 18, 2026

Mar 18, 2026

This Sezzle analyst begins coverage on a bullish note; here are top 3 initiations for Thursday - MSN

Mar 18, 2026

Mar 17, 2026

Stephens & Co. Maintains Immunome (IMNM) Overweight Recommendation - MSN

Mar 17, 2026

Mar 17, 2026

Immunome Inc Stock (ISIN: US45254C1062) Eyes Upside as Lock-Up Expires Today Amid Short-Term Buy Sig - AD HOC NEWS

Mar 17, 2026

Mar 16, 2026

Forecast Cut: What is the long term forecast for Immunome Inc stockBond Market & Fast Gain Stock Trading Tips - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

Certain Stock Options of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2026. - marketscreener.com

Mar 16, 2026

Mar 16, 2026

Certain Common Stock of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2026. - marketscreener.com

Mar 16, 2026

Mar 15, 2026

Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% - AOL.com

Mar 15, 2026

Mar 14, 2026

Pivotal bioVenture Partners Investment Advisor LLC Invests $5.88 Million in Immunome, Inc. $IMNM - MarketBeat

Mar 14, 2026

Mar 13, 2026

Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing - AOL.com

Mar 13, 2026

Mar 12, 2026

Loss Report: Is Immunome Inc forming a breakout pattern2026 Risk Factors & Weekly Stock Breakout Alerts - baoquankhu1.vn

Mar 12, 2026

Mar 12, 2026

Bienaime buys Immunome (IMNM) shares worth $43,670 - Investing.com Nigeria

Mar 12, 2026

Mar 12, 2026

Insider Buying: Jean Bienaime Acquires Additional Shares of Immu - GuruFocus

Mar 12, 2026

Mar 12, 2026

Bienaime buys Immunome (IMNM) shares worth $43,670 By Investing.com - Investing.com South Africa

Mar 12, 2026

Mar 12, 2026

Immunome (NASDAQ:IMNM) Director Acquires $21,550.00 in Stock - MarketBeat

Mar 12, 2026

Mar 12, 2026

Immunome (IMNM) director buys 2,000 shares in open market - Stock Titan

Mar 12, 2026

Mar 11, 2026

Craig-Hallum Initiates Coverage of Immunome (IMNM) with Buy Recommendation - MSN

Mar 11, 2026

Mar 11, 2026

A Look At Immunome (IMNM) Valuation After Narrower 2025 Loss And New US$156 Million Shelf Registration - simplywall.st

Mar 11, 2026

Mar 11, 2026

Immunome: Upcoming NDA, Valuation, And Investment Case (NASDAQ:IMNM) - Seeking Alpha

Mar 11, 2026

Mar 11, 2026

Immunome (IMNM) to Release Earnings on Wednesday - MarketBeat

Mar 11, 2026

Mar 08, 2026

(IMNM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Mar 08, 2026

Mar 07, 2026

Immunome (NASDAQ:IMNM) Downgraded by Wall Street Zen to "Sell" - MarketBeat

Mar 07, 2026

Mar 07, 2026

Is Immunome Inc forming a breakout patternJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Immunome (IMNM) - The Globe and Mail

Mar 07, 2026

Mar 06, 2026

Did Reduced 2025 Losses and NDA Plans Just Shift Immunome's (IMNM) Investment Narrative? - finance.yahoo.com

Mar 06, 2026

Mar 06, 2026

Whale Trades: How do insiders feel about Immunome IncMarket Sentiment Review & Entry and Exit Point Strategies - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

HC Wainwright Brokers Raise Earnings Estimates for Immunome - MarketBeat

Mar 06, 2026

Mar 06, 2026

Immunome (IMNM) TTM Net Loss Of US$212 Million Reinforces Bearish Profitability Narratives - Sahm

Mar 06, 2026

Mar 05, 2026

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com

Mar 05, 2026

Mar 05, 2026

HC Wainwright Analysts Boost Earnings Estimates for Immunome - MarketBeat

Mar 05, 2026

Mar 04, 2026

IMNM: Stephens & Co. Lowers Price Target to $30, Maintains Overw - GuruFocus

Mar 04, 2026

Mar 04, 2026

Immunome (IMNM): Craig-Hallum Raises Price Target to $36.00 and - GuruFocus

Mar 04, 2026

Mar 04, 2026

Immunome (NASDAQ:IMNM) Price Target Raised to $36.00 - MarketBeat

Mar 04, 2026

Mar 04, 2026

Stephens Cuts Immunome (NASDAQ:IMNM) Price Target to $30.00 - MarketBeat

Mar 04, 2026

Mar 04, 2026

Decoding Immunome Inc (IMNM): A Strategic SWOT Insight - GuruFocus

Mar 04, 2026

Mar 03, 2026

Immunome (IMNM) Reports Wider Losses and Revenue Decline - GuruFocus

Mar 03, 2026

Mar 03, 2026

Immunome 2025 Net Loss Narrows - marketscreener.com

Mar 03, 2026